World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
9485
World Ranking
4332
National Ranking
288

Jan D. Lünemann publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jan D. Lünemann sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 156 publications — 18th percentile

18% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jan D. Lünemann D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jan D. Lünemann sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jan D. Lünemann is a researcher affiliated with the University Hospital of Münster in Germany focusing on medicine, immunology, and neurology. Their work spans multiple subfields, including neurology, immunology, pathology and forensic medicine, molecular biology, and oncology.

Their research covers a range of topics primarily centered on neurological and immunological disorders. Main themes include multiple sclerosis research studies, peripheral neuropathies and disorders, myasthenia gravis and thymoma, T-cell and B-cell immunology, immune cell function and interaction, neuroinflammation and neurodegeneration mechanisms, and immunotherapy and immune responses.

Recent publications by Jan D. Lünemann include:

  • Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study (2023) in The Lancet Neurology
  • Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper) (2021) in Therapeutic Advances in Neurological Disorders
  • Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis (2021) in Neurology Neuroimmunology & Neuroinflammation
  • NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients (2020) in Brain
  • International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis (2024) in Autophagy

Lünemann has frequently published in the following venues:

  • Neurology Neuroimmunology & Neuroinflammation (11 publications)
  • Annals of Neurology (5 publications)
  • Frontiers in Immunology (5 publications)
  • Brain (4 publications)
  • Autophagy (4 publications)

Collaborations form an important part of their research activity. Frequent co-authors include Heinz Wiendl, Christian W. Keller, Luisa Klotz, Xavier Montalbán, and Catharina C. Groß.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif

  • Antiviral immune responses: triggers of or triggered by autoimmunity?

    Christian Münz;Jan D. Lünemann;Meghann Teague Getts;Stephen D. Miller

  • EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2

    Jan D. Lünemann;Ilijas Jelčić;Susanne Roberts;Andreas Lutterotti

  • Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

    Jan D. Lünemann;Falk Nimmerjahn;Marinos C. Dalakas

  • Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity

    Isaak Quast;Christian W. Keller;Michael A. Maurer;John P. Giddens

  • Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosis

    Jan D. Lünemann;Mar Tintoré;Brady Messmer;Brady Messmer;Till Strowig

  • Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

    Björn Tackenberg;Ilijas Jelčić;Anne Baerenwaldt;Wolfgang H. Oertel

  • Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

    Jan D. Lünemann;Nancy Edwards;Paolo A. Muraro;Shuhei Hayashi

  • TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis

    Klaus-Peter Wandinger;Jan D Lünemann;Oliver Wengert;Judith Bellmann-Strobl

  • A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis

    M. Comabella;J. D. Lünemann;J. Río;A. Sánchez

  • Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity

    Unknown

  • Infectious causes of multiple sclerosis

    Gavin Giovannoni;Gary R Cutter;Jan Lunemann;Roland Martin

  • Viral triggers of multiple sclerosis

    Kristina Kakalacheva;Christian Münz;Jan D. Lünemann

  • Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (Auto)antigen-Specific T Cells

    Jan D. Lünemann;Sonia Waiczies;Stefan Ehrlich;Uwe Wendling

  • Regulatory NK-cell functions in inflammation and autoimmunity.

    Anna Lünemann;Jan D. Lünemann;Christian Münz

  • Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop.

    Maria Pia Amato;Tobias Derfuss;Bernard Hemmer;Roland Liblau

  • Epstein-Barr Virus: Environmental Trigger of Multiple Sclerosis?

    Jan D. Lünemann;Thomas Kamradt;Roland Martin;Christian Münz

  • β-amyloid is a substrate of autophagy in sporadic inclusion body myositis

    Jan D. Lünemann;Jens Schmidt;Dorothee Schmid;Konstanze Barthel

  • TNF-alpha induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells

    Christian W. Keller;Claudia Fokken;Stuart G. Turville;Anna Lünemann;Anna Lünemann

  • NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

    Sunny Malhotra;Carme Costa;Herena Eixarch;Christian W Keller;Christian W Keller

  • Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis

    Unknown

  • Epstein-Barr virus and multiple sclerosis

    Jan D. Lünemann;Christian Münz

Frequent Co-Authors

Heinz Wiendl
Heinz Wiendl University of Münster
Russell C. Dale
Russell C. Dale University of Sydney
Christian Münz
Christian Münz University of Zurich
Atanas G. Atanasov
Atanas G. Atanasov Medical University of Vienna
Tiago F. Outeiro
Tiago F. Outeiro University of Göttingen
Philippe Pierre
Philippe Pierre Aix-Marseille University
Luisa Klotz
Luisa Klotz University Hospital Münster
Catharina C. Gross
Catharina C. Gross University of Münster
Antonio Cuadrado
Antonio Cuadrado Autonomous University of Madrid
Changlian Zhu
Changlian Zhu University of Gothenburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related health science degrees can open diverse career opportunities. Nursing pathways, for example, provide a strong foundation in patient care and clinical sciences, which complement immunological expertise.

Many aspiring nurses start with the easiest absn program to get into, allowing for a quicker transition into nursing roles. Similarly, those beginning their healthcare journey might consider lpn programs easy to get into, offering practical training and a stepping stone toward advanced roles.

As professionals advance, selecting from the easiest np programs to get into ensures access to nurse practitioner education with manageable admission criteria. For specialized mental health nursing, online pmhnp programs with clinical placement opportunities are crucial, ensuring hands-on experience in psychiatric care settings.

Understanding these pathways can help Immunology students tailor their education toward impactful careers in healthcare and research. Combining Immunology with nursing credentials or mental health specialization can lead to vital roles in patient treatment, clinical trials, and public health.

Best Scientists Citing Jan D. Lünemann

Trending Scientists

Recently Published Articles